跳至主要内容
临床试验/PER-018-02
PER-018-02已完成未知

A DOUBLE BLIND COMPARISON CONTROLLED WITH PLACEBO, RANDOMIZED OF THE EFFICACY AND SAFETY OF CELECOXIB 200 MG AND CELECOXIB 400MG ONCE A DAY IN THE TREATMENT OF THE SIGNS AND SYMPTOMS OF PSORIASTIC ARTHRITIS

PHARMACIA & UPJOHN INTERAMERICAN CORPORATION,0 个研究点目标入组 0 人开始时间: 2002年2月22日最近更新:

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • The patients has an established diagnosis of Psoriasis.
  • The patients has a presentation of psoriatic arthritis as a compromise of distal intephalangeal joints, asymmetric peripheral arthritis or symmetric poly arthritis.
  • The patients is a man or woman 18 years of age or older.

排除标准

  • The patients has any other inflammatory arthritis (eg, rheumatoid arthritis).
  • The patients has a positive rheumatoid factor (> 20 lU / ml).
  • The patients has a history of Inflammatory Bowel Disease.
  • The patients has a significant secondary non-inflammatory arthritis (eg, severe osteoarthritis).

研究者

发起方
PHARMACIA & UPJOHN INTERAMERICAN CORPORATION,

相似试验